Vyome Competitors
| HIND Stock | 2.61 0.05 1.95% |
Vyome Holdings vs OmniAb Correlation
Good diversification
The correlation between Vyome Holdings and OABI is -0.2 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Vyome Holdings and OABI in the same portfolio, assuming nothing else is changed.
Moving together with Vyome Stock
Moving against Vyome Stock
| 0.82 | IMMP | Immutep Ltd ADR | PairCorr |
| 0.68 | ENGN | enGene Holdings Common | PairCorr |
| 0.66 | DSGN | Design Therapeutics | PairCorr |
| 0.52 | 63E | ONWARD MEDICAL BV | PairCorr |
| 0.48 | KYTX | Kyverna Therapeutics | PairCorr |
Vyome Holdings Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Vyome Holdings and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Vyome and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Vyome Holdings does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Vyome Stock performing well and Vyome Holdings Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Vyome Holdings' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CCCC | 3.30 | (0.39) | 0.00 | (0.19) | 0.00 | 8.06 | 25.16 | |||
| ARMP | 5.19 | 0.69 | 0.11 | 0.70 | 6.08 | 14.07 | 36.30 | |||
| SGMO | 4.66 | (0.22) | 0.00 | (0.01) | 0.00 | 9.52 | 73.25 | |||
| CGEN | 2.99 | 0.04 | 0.01 | 0.11 | 3.27 | 6.57 | 23.25 | |||
| NVCT | 2.61 | 0.51 | 0.19 | 0.48 | 2.40 | 6.17 | 17.53 | |||
| IPHA | 2.39 | (0.04) | 0.00 | (0.11) | 0.00 | 3.41 | 39.49 | |||
| IMDX | 4.27 | (0.21) | 0.00 | (0.01) | 0.00 | 9.42 | 35.29 | |||
| CDXS | 3.75 | (0.63) | 0.00 | (0.16) | 0.00 | 6.21 | 22.77 | |||
| OABI | 2.68 | 0.24 | 0.10 | 0.22 | 2.53 | 7.97 | 15.55 |
Cross Equities Net Income Analysis
Compare Vyome Holdings and related stocks such as C4 Therapeutics, Armata Pharmaceuticals, and Sangamo Therapeutics Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CCCC | (15.7 M) | (15.7 M) | (15.7 M) | (15.7 M) | (15.7 M) | (15.7 M) | (15.7 M) | (15.7 M) | (15.7 M) | (34.1 M) | (66.3 M) | (83.9 M) | (128.2 M) | (132.5 M) | (105.3 M) | (94.8 M) | (99.5 M) |
| ARMP | (5.1 M) | (3.8 M) | (1.1 M) | (64.6 M) | 23.1 M | (516 K) | (18.8 M) | (12.8 M) | (12.1 M) | (19.5 M) | (22.2 M) | (23.2 M) | (36.9 M) | (69 M) | (18.9 M) | (17 M) | (17.9 M) |
| SGMO | (308 K) | (35.8 M) | (22.3 M) | (26.6 M) | (26.4 M) | (40.7 M) | (71.7 M) | (54.6 M) | (68.3 M) | (75.8 M) | (121.1 M) | (178.3 M) | (192.3 M) | (257.8 M) | (97.9 M) | (88.1 M) | (83.7 M) |
| CGEN | (8.1 M) | (12 M) | (13.6 M) | (14.1 M) | (11.1 M) | (20.2 M) | (31.5 M) | (37.1 M) | (22.6 M) | (27.3 M) | (27.3 M) | (32.9 M) | (33.7 M) | (18.8 M) | (14.2 M) | (12.8 M) | (13.4 M) |
| NVCT | (10 K) | (10 K) | (10 K) | (10 K) | (10 K) | (10 K) | (10 K) | (10 K) | (10 K) | (10 K) | (10 K) | (12.9 M) | (18.8 M) | (22.3 M) | (19 M) | (28.9 M) | (27.4 M) |
| IPHA | (6.1 M) | (7 M) | (3.2 M) | (2.9 M) | (19.6 M) | (6.7 M) | 12.6 M | (48.4 M) | 3 M | (20.8 M) | (64 M) | (52.8 M) | (58.1 M) | (7.6 M) | (49.5 M) | (44.5 M) | (42.3 M) |
| IMDX | (3.5 M) | (3.5 M) | (3.5 M) | (3.5 M) | (5 M) | (8.7 M) | (11.2 M) | (19.4 M) | (15.8 M) | (22.3 M) | (29.9 M) | (64.1 M) | (72.9 M) | (27.8 M) | (60.7 M) | (54.6 M) | (51.9 M) |
| CDXS | (18.7 M) | (16.6 M) | (30.9 M) | (41.3 M) | (19.1 M) | (7.6 M) | (8.6 M) | (23 M) | (10.9 M) | (11.9 M) | (24 M) | (21.3 M) | (33.6 M) | (76.2 M) | (65.3 M) | (58.7 M) | (55.8 M) |
| OABI | (13.6 M) | (13.6 M) | (13.6 M) | (13.6 M) | (13.6 M) | (13.6 M) | (13.6 M) | (13.6 M) | (13.6 M) | (13.6 M) | (17.6 M) | (27 M) | (22.3 M) | (50.6 M) | (62 M) | (55.8 M) | (53 M) |
Vyome Holdings and related stocks such as C4 Therapeutics, Armata Pharmaceuticals, and Sangamo Therapeutics Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Vyome Holdings financial statement analysis. It represents the amount of money remaining after all of Vyome Holdings operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Vyome Holdings Competitive Analysis
The better you understand Vyome Holdings competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Vyome Holdings' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Vyome Holdings' competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Vyome Holdings Competition Performance Charts
Five steps to successful analysis of Vyome Holdings Competition
Vyome Holdings' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Vyome Holdings in relation to its competition. Vyome Holdings' competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Vyome Holdings in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Vyome Holdings' competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Vyome Holdings, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Vyome Holdings position
In addition to having Vyome Holdings in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Precious Metals Funds Thematic Idea Now
Precious Metals Funds
Funds or Etfs that invest in entities that are involved in mining, processing or dealing of precious metals. The Precious Metals Funds theme has 33 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Precious Metals Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Vyome Holdings Correlation with its peers. For information on how to trade Vyome Stock refer to our How to Trade Vyome Stock guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Will Biotechnology sector continue expanding? Could Vyome diversify its offerings? Factors like these will boost the valuation of Vyome Holdings. Market participants price Vyome higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Vyome Holdings data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Vyome Holdings requires distinguishing between market price and book value, where the latter reflects Vyome's accounting equity. The concept of intrinsic value - what Vyome Holdings' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Vyome Holdings' price substantially above or below its fundamental value.
Please note, there is a significant difference between Vyome Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vyome Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Vyome Holdings' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.